Abbott

By Mallory Hackett 03:06 pm July 1, 2020
Walgreens Boots Alliance expanded its partnership with Microsoft and Adobe to launch a digital platform that will deliver personalized healthcare and shopping offerings. It will give Walgreens and Boots customers the ability to access products and services from its pharmacy and retail businesses wherever and whenever they want. This marks WBA’s second phase of its digital transformation. “At WBA...
By Laura Lovett 03:15 pm June 15, 2020
This morning Abbott revealed that its much anticipated integrated continuous glucose monitoring system the FreeStyle Libre 2 is now FDA cleared for adults and kids over the age of 4 with diabetes.  The latest product is able to continuously transmit glucose data every minute, and users can set the system to send alarms when their glucose is too high or too low. Previously users had to scan the...
By Dave Muoio 02:37 pm June 15, 2020
The American Diabetes Association's 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers and service providers highlighted new data as part of the virtual clinical conference. Read on for summaries of the studies and findings, as well as links to the online abstracts. Onduo Verily-backed diabetes management service Onduo, which combines a mobile app...
By Mallory Hackett 09:54 am June 9, 2020
A new study published in US Endocrinology found Abbott’s continuous glucose monitoring system, the FreeStyle Libre, demonstrated significant cost savings for diabetic care compared to traditional fingerstick testing.  Abbott’s system uses flash continuous glucose monitoring (CGM) through a sensor placed to the back of the upper arm, and lasts for up to 14 days. The device automatically collects...
By Laura Lovett 01:55 pm June 3, 2020
This morning Bigfoot Biomedical, a diabetes startup focused on automating insulin delivery through a connected insulin pen, picked up an extra $10 million Series C funding, closing the round at $55 million. Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders.  When the first $45 million...

Credit: Babylon

By Tammy Lovell 09:39 am May 15, 2020
British digital health company Babylon is offering COVID-19 antibody tests to anyone in the UK for its at cost price. The FDA-approved tests, which do not have to be administered by a healthcare professional, can be taken at home and sent for analysis in a third-party lab, to determine whether or not a person has been previously infected by the virus. Users can choose to opt-in to share...
By Jonah Comstock 03:43 pm February 20, 2020
Insulin pump maker Insulin announced partnerships yesterday with two of the leading continuous glucose monitor companies, Abbott and Dexcom. Both involve the Insulet’s Omnipod Horizon Automated Insulin Delivery System which uses a tubeless, wearable “Pod” to deliver insulin for 72 hours at a time. Abbott and Insulet have partnered to offer a new integrated digital health platform that will...
By Dave Muoio 01:40 pm January 27, 2020
Abbott’s Infinity Deep Brain Stimulation (DBS) system has received an expanded clearance from the FDA that now permits the targeted stimulation of a new area of the brain associated with Parkinson’s disease symptoms. By now targeting the internal globus pallidus alongside the subthalamic nucleus and ventral intermediate nucleus, the company says that its system “is now the only directional DBS...
By Dave Muoio 11:31 am January 16, 2020
Bigfoot Biomedical, a diabetes startup looking to automate insulin delivery via a connected insulin pen, has kicked off its Series C round with an initial tranche of $45 million. The raise is headed once again by Abbott, with prior backers Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management pitching in once again. Alongside the news of its raise, Bigfoot...
By Laura Lovett 04:18 pm October 14, 2019
This morning med tech giant Abbott announced a new deal with chronic care management company Omada Health that will integrate Abbott’s FreeStyle Libre continuous glucose monitor (CGM) with Omada's health coaching platform.  Going forward, eligible users with Type 2 diabetes will have the option to integrate data from their FreeStyle Libre, including glucose reading, trends and patterns, with...